Syros Pharmaceuticals Inc. (SYRS) Fundamentals

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
SHARE INFORMATION
Market Cap$ 61,115,136
Shares Outstanding63,005,295
Float48,457,246
Percent Float76.91%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 23,488,000
Latest Fiscal EPS$ -1.37
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions220
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months2,524,225
Institutional Holdings Percent78.5%
Institutional Sold Previous 3 Months11,790,845
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months175,000
Insider Holdings Percent2.5
Insider Sold Previous 3 Months-
Insider Shares Owned1,578,418
TRADING INFO
52 Week High$ 5.64
52 Week Low$ 0.65
52 Week High Change$ -77.60
21 Day Moving Average$ 0.9136
21 Day Extended Moving Average$ 0.922995
50 Day Moving Average$ 0.936
50 Day Extended Moving Average$ 0.931104
200 Day Moving Average$ 1.8447
200 Day Extended Moving Average$ 1.9775
10 Day Average Volume1,703,707
20 Day Average Volume1,025,093
30 Day Average Volume811,087
50 Day Average Volume887,505
Alpha-0.043947
Beta1.6619
Standard Deviation0.232004
R20.128368
7 Day Price Change$ 0.0427
7 Day Percent Change4.6%
21 Day Price Change$ 0.10
21 Day Percent Change11.49%
30 Day Price Change$ 0.035
30 Day Percent Change3.74%
Month to Date Price Change$ 0.185
Month to Date Percent Change23.57%
Quarter to Date Price Change$ 0.0073
Quarter to Date Percent Change0.76%
180 Day Price Change$ -0.60
180 Day Percent Change-38.22%
200 Day Price Change$ -0.96
200 Day Percent Change-49.74%
Year to Date Price Change$ -2.29
Year to Date Percent Change-70.25%

Syros Pharmaceuticals Inc. (SYRS) Key Ratios

PROFITABILITY
EBIT Margin-418.1%
EBITDA Margin-406.2%
Pre-Tax Profit Margin-2,522.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 25,242,000
Revenue Per Share$ 0.4006
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.10
Total Debt To Equity2.10
Int Coverage-26.90
Current Ratio2.40
Leverage Ratio2.40
Quick Ratio2.30
Long Term Debt To Capital0.64
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 41,947,347
Price to Sales2.4212
Price to Free Cash-0.60
PE High Last 5 Years-3.90
Price To Book2.10
Price To Cash Flow0.00
PE Low Last 5 Years-2.50
Price to Tangible Book2.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover11.20
Invoice Turnover0.00
Assets Turnover0.20
Return Assets-65.79
Return on Equity-150.08
Return on Capital-72.60

Syros Pharmaceuticals Inc. (SYRS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEONancy A. Simonian
Emplyoees124
Last AuditUE
CIK0001556263
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address35 CambridgePark Drive
4th Floor
Cambridge, MA 2140
Websitehttps://www.syros.com
Facsimile-
Telephone+1 617 744-1340
Email-


Your Recent History
NASDAQ
SYRS
Syros Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.